Tony DiMaio
Head of Investor Relations
Replay available
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2025 Earnings Call
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) Q1 2025 earnings conference call, held 2025-05-02. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Chirag Patel
Co-Founder and Co-CEO
Shintu Patel
Co-Founder and Co-CEO
Tasos Conidera
Chief Financial Officer
David Anselm
Analyst at Piper Sandler
Les Lewicki
Analyst at Truro Securities
Chris Schott
Analyst at JPMorgan
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Amneal Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.132 -- 00:00:05.418 Good morning and welcome to the Amniel Pharmaceuticals First Quarter 2025 Earnings 00:00:05.418 -- 00:00:10.624 Call. I'd now like to turn the call over to Amniel's Head of Investor Relations, Tony 00:00:10.624 -- 00:00:12.624 DiMaio. 00:00:14.008 -- 00:00:19.233 Good morning, and thank you for joining Amniel Pharmaceuticals First Quarter 2025 Earnings 00:00:19.233 -- 00:00:23.698 Call. Today, we issued a press release reporting Q1 results. 00:00:23.698 -- 00:00:28.482 The earnings press release and presentation are available at amniel.com. 00:00:28.482 -- 00:00:32.987 Certain statements made on this call regarding matters that are not historical facts, 00:00:32.987 -- 00:00:37.132 including but not limited to management's outlook or predictions, are forward-looking 00:00:37.132 -- 00:00:43.119 statements that are based solely on information that is now available to us. 00:00:43.119 -- 00:00:48.065 We see this section entitled Cautionary Statements on Forward-Looking Statements 00:00:48.065 -- 00:00:51.890 for factors that may impact future performance. 00:00:51.890 -- 00:00:57.533 We also discussed non-GAAP measures. Information on use of these measures and reconciliations 00:00:57.533 -- 00:01:01.599 to GAAP are in the earnings release and presentation. 00:01:01.599 -- 00:01:07.188 On the call today are Chirag and Shintu Patel, co-founders and co-CEOs. 00:01:07.188 -- 00:01:12.196 Tasos Conidera, CFO. Our commercial leaders, Andy Boyer for Affordable 00:01:12.196 -- 00:01:17.965 Medicines, Joe Renda for Specialty, and Jason Daly, Chief Legal Officer. 00:01:17.965 -- 00:01:21.690 I will now hand the call over to Chirag. Thank you, Tony. 00:01:21.690 -- 00:01:26.867 Good morning, everyone. In Q1, we delivered another quarter of 00:...